EVALUATION OF ENDOSCOPIC TREATMENT OF THE PANCREATOBILIARY SYSTEM DISORDERS

Endoscopic retrograde cholangiopancreatography (ERCP) is becoming more widespread in the treatment of diseases of the bile ducts and pancreas. Studying the therapeutic and diagnostic capabilities of the ERCP and the complications accompanying this method made it possible to reconsider the indications and contraindications for its use, the main of which is the removal of concretions from the bile ducts and the stenting in the case of duct obturation with neoplasms. The purpose of the paper is to study the effectiveness and safety of endoscopic methods of treating pancreatobiliary pathology. The results of the endoscopic treatment of 412 patients with diseases of the pancreatobiliary system who were on the treatment at the center of endoscopic surgery are presented in this research paper. Primary surgical interventions were performed in 319 patients (77.43%). The cannulation of the desired duct with guidewire was achieved in 284 patients (68.93%). The most common indication for endoscopic interventions was mechanical jaundice caused by concretions in the common bile duct in combination with calculous cholecystitis 209 patients (50,72%), recurrent choledocholithiasis was observed in 26 patients (6,31%), neoplasms in the hepatopancreatoduodenal zone were found in 130 patients (31,55%). Extraction of concrements from extrahepatic bile ducts was carried out in 235 patients (57,03%). Endobiliary stenting was performed in 158 (38,34%) patients in 122 (29,61%) of them due to pancreatic tumors and extrahepatic biliary tract. The frequency of occurrence of postoperative complications does not exceed 7,8%. Thus, ERCP is highly effective diagnostic and treatment method that do not require general anesthesia, do not cause significant surgical trauma, avoiding open surgery and improving the immediate and long-term outcomes of treatment.